FdaApplication
NDA 212018
Identifiers
- fda_app_no: NDA212018
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN BIOTECH INC |
| application_type | NDA |
| approval_date | 2019-04-12 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BALVERSA | ERDAFITINIB | 3MG | TABLET;ORAL |
| BALVERSA | ERDAFITINIB | 4MG | TABLET;ORAL |
| BALVERSA | ERDAFITINIB | 5MG | TABLET;ORAL |
3 products